Aspartylglucosaminidase (AGA) (Middle Region) Peptide
AGA
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all AGA products
- AGA (Aspartylglucosaminidase (AGA))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SMGFINEDLS TTASQALHSD WLARNCQPNY WRNVIPDPSK YCGPYKPPGI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AGA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AGA (Aspartylglucosaminidase (AGA))
- Background
-
Aspartylglucosaminidase is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. The lysosomal storage disease aspartylglycosaminuria is caused by a deficiency in the AGA enzyme.
Alias Symbols: AGU, ASRG, GA
Protein Interaction Partner: AGA,ALB,IGF2R,AGA
Protein Size: 336 - Molecular Weight
- 36 kDa
- Gene ID
- 175
- NCBI Accession
- NM_001171988, NP_001165459
- UniProt
- P20933
-
You are here:
